Medical/Pharmaceuticals
111, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results
SHANGHAI, March 17, 2022 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the fourth qua...
2022-03-17 15:20
3131
Henlius 2021 Annual Results: New Record in Performance, Evolving to Biopharma
SHANGHAI, March 17, 2022 /PRNewswire/ -- Henlius (2696.HK) announced its annual results for the year endedDecember 31st, 2021, sharing the company's recent noteworthy progress and achievements. As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, afford...
2022-03-17 08:00
5383
Henlius 2021 Annual Results: New Record in Performance, Evolving to Biopharma
SHANGHAI, March 16, 2022 /PRNewswire/ -- Henlius (2696.HK) announced its annual results for the year endedDecember 31st, 2021, sharing the company's recent noteworthy progress and achievements. As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, afford...
2022-03-16 23:46
2778
Breakthrough Study Validates Artificial Intelligence as a Novel Biomarker in Predicting Immunotherapy Response - Published in Journal of Clinical Oncology
* Lunit's latest study provides evidence for Lunit SCOPE IO's ability to predict immunotherapy response * This is the first study that adopted AI technology to define the tumor immune phenotype and to demonstrate its ability in predicting treatment outcomes of anti-PD-L1 therapy SEOUL, South ...
2022-03-16 21:09
2782
SyMap Targets Renal Denervation With a Unique Map-and-Ablate Technology
SUZHOU, China, March 16, 2022 /PRNewswire/ -- SyMap Medical is developing a selective map-and-ablate technology that has the potential to substantially improve outcomes following renal denervation for treatment-resistant hypertension. Recent setbacks in renal denervation (RDN) clinical trials ...
2022-03-16 21:00
2358
Terran Biosciences announces licensing deal with Columbia University for exclusive worldwide rights to proprietary CNS biomarker software platform
NEW YORK, March 16, 2022 /PRNewswire/ -- Terran Biosciences, Inc. ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics and technologies for neurological and psychiatric diseases, has entered into an agreement withColumbia University ("Columbia") and...
2022-03-16 20:38
4823
Innoforce and Hibiscus BioVentures Announce Strategic Partnership to Enable Development of Advanced Therapies
- Partnership enables Hibiscus BioTechnology Studio Companies access to Innoforce's advanced therapies drug development capabilities - HANGZHOU, China and ROCKVILLE, Md., March 16, 2022 /PRNewswire/ -- Innoforce, a global development and biomanufacturing company focused on Advanced Therapy Medic...
2022-03-16 19:00
2938
Adagene Announces FDA Clearance to Proceed with Phase 1b/2 Trial of Anti-CTLA-4 ADG126 SAFEbody® in Combination Therapy With Anti-PD-1 Antibody Pembrolizumab
SAN DIEGO and SUZHOU, China, March 16, 2022 /PRNewswire/ -- Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced FDA clearance to proceed with a Phase1b/2 clinical trial of its anti-CTLA-4 monoclonal antib...
2022-03-16 19:00
4152
Mentice receives order of ten (10) VIST simulator systems in China for a value exceeding 500,000 USD
STOCKHOLM, March 16, 2022 /PRNewswire/ -- Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China via an official importation agent, has placed an order of ten (10) Mentice VIST simulator packages including the Sie...
2022-03-16 15:43
2334
Beyond a platform, Ping An Good Doctor aiming to be a pillar of China's healthcare sector
HONG KONG and SHANGHAI, March 16, 2022 /PRNewswire/ -- In the second year of the COVID-19 pandemic,Ping An Good Doctor's value proposition of providing users with an "easier, faster and more affordable" digital health experience found resonance with all segments of society. There is still a long...
2022-03-16 15:17
4252
Chang Il-Moo, a former head of R&D department at KGC, wins James A. Duke award from the American Botanical Council
SEOUL, South Korea and ANAHEIM, Calif., March 16, 2022 /PRNewswire/ -- Chang Il-Moo, who successively served as the head of R&D department at the Korea Ginseng Corporation (KGC, CEOKim Jae-Su), won the 2021 Duke Award, the top writing award granted by the American Botanical Council (ABC), forA Hi...
2022-03-16 15:15
2874
SNIPR BIOME expands its Executive Management team and opens offices in the US and UK
COPENHAGEN, Denmark, March 16, 2022 /PRNewswire/ -- SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, today announced the appointment of Jasper Clube as Chief Intellectual Property Officer from 1 February 2022 and Stephanie Krebs as Chief Business Officer from 14 March 2022. ...
2022-03-16 14:28
2251
Pasture Announces First Halal-Certified Surgical N95 Masks for Healthcare and Public Use
SINGAPORE, March 16, 2022 /PRNewswire/ -- Pasture Group, the leading global
medical device manufacturer and pharmaceutical company inSingapore, unveils its
accreditation as the world's top halal-certified US FDA-approved N95 mask
producer for healthcare and public use.
2022-03-16 13:00
3297
Gene Solutions Makes Earlier Detection of Cancer A Possibility of the Future
HO CHI MINH CITY, Vietnam, March 16, 2022 /PRNewswire/ -- The scientific
research team fromGene Solutions
2022-03-16 09:36
4959
Brii Bio Announces that National Health Commission of China Adds Amubarvimab/Romlusevimab Combination to its COVID-19 Diagnosis and Treatment Guidelines (9th Pilot Edition)
The amubarvimab/romlusevimab combination is the first locally-discovered and approved SARS-CoV-2 target-specific treatment inChina, through a randomized, double-blind and placebo-controlled trial In vitro tests shows that amubarvimab/romlusevimab combination retains neutralizing activity against...
2022-03-16 09:00
4496
Korea Health Industry Development Institute operates Korean Pavilion at 'HIMSS Global Health Conference & Exhibition'
- Presenting the latest healthcare technologies with leading innovation companies ofSouth Korea ORLANDO, Fla., March 15, 2022 /PRNewswire/ -- Korea Health Industry Development Institute (KHIDI) announced its operation of the Korean pavilion at the 2022 HIMSS Global Health Conference& Exhibition ...
2022-03-16 06:44
2576
United Imaging Receives Contract from Vizient for its X-ray and Magnetic Resonance Imaging Systems
HOUSTON, March 15, 2022 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has received a contract from Vizient, Inc., for its entire portfolio of DR (X-Ray) and MR (magnetic resonance) systems. The contract expands the number of modalities off...
2022-03-15 21:00
2521
Evercare Group launches Evercare Foundation to help bridge the gap in inequality in healthcare
- The Foundation will provide long-term solutions to improve healthcare access inAfrica and South Asia, while contributing to the 2030 Sustainable Development Goals. ISLAMABAD, Pakistan, March 15, 2022 /PRNewswire/ -- The Evercare Group today announced the launch of the Evercare Foundation, a no...
2022-03-15 20:22
2177
ROKIT Healthcare's Latest Paper About Its AI Technology Has Been Accepted to CVPR 2022
SEOUL, South Korea, March 15, 2022 /PRNewswire/ -- ROKIT Healthcare, a global hyper-personalized organ regeneration company, announced onMarch 7th that its paper about the "AI and 3D bioprinting convergence technology for regenerative treatments" has been accepted to 2022 IEEE/CVF Conference on C...
2022-03-15 20:00
2793
I-Mab Provides Updates Regarding Holding Foreign Companies Accountable Act
SHANGHAI and GAITHERSBURG, Md., March 15, 2022 /PRNewswire/ -- I-Mab ( "I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today provides updates on the recent development relating ...
2022-03-15 20:00
2351
Week's Top Stories
Most Reposted
/C O R R E C T I O N - Autodesk, Inc./
[Picked up by 1321 media titles]
2026-10-29 01:23
TD Brings its Global Asset Management Businesses Under One Name
[Picked up by 1167 media titles]
2026-11-02 20:00Waters Launches AI-Powered Peak Integration Expanding its Suite of Premium AI Subscription Capabilities for Empower Software
[Picked up by 1148 media titles]
2026-10-28 20:30Piramal Pharma Limited Announces Results for Q2 and H1 FY27
[Picked up by 1084 media titles]
2026-10-28 03:28Fintech OPay Raises $304 Million Ahead of NYSE Debut: NYSE Content Update
[Picked up by 1079 media titles]
2026-10-30 22:34
Most Read
1B views since June: Coda and TikTok Gaming turn content into commerce
2026-11-02 09:35
55457
iQIYI Launches China's First AI Film Studio in Shanghai, with Inaugural Title "Cop in Trouble" in Production
2026-11-02 09:52
48554
Airbrush Upgrades AI Image Enhancer With 16K Output and Batch Processing for Up to 50 Images
2026-11-03 02:00
36941
